Valuation: Mega Lifesciences

Market Cap 2.86TCr 85Cr 76Cr 70Cr 63Cr 118.43Cr 8.07TCr 120.35Cr 835.01Cr 333.12Cr 4.22TCr 317.87Cr 311.1Cr 13TCr P/E 2026 *
12.5x
P/E 2027 * 11.5x
Enterprise Value 2.39TCr 71Cr 64Cr 59Cr 53Cr 99Cr 6.76TCr 100.89Cr 700Cr 279.26Cr 3.54TCr 266.47Cr 260.8Cr 11TCr EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.54x
Free-Float
38.66%
Yield 2026 *
5.44%
Yield 2027 * 5.83%
1 day-3.68%
1 week-2.24%
Current month-2.96%
1 month-5.07%
3 months-12.67%
6 months-6.43%
Current year-2.24%
1 week 32.5
Extreme 32.5
34.75
1 month 32.5
Extreme 32.5
34.75
Current year 31.5
Extreme 31.5
40
1 year 28.75
Extreme 28.75
40
3 years 24.3
Extreme 24.3
44.25
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Change 5-day change 1-year change 3-year change Capi.($)
-3.68%-2.24% - - 88Cr
+6.63%+8.10%+67.50%+145.20% 1,14800Cr
+1.53%+6.76%+47.22%+89.01% 65TCr
+1.68%+2.10%+27.80%+109.31% 51TCr
+0.73%+2.47%+53.85%+68.96% 38TCr
+3.83%-2.37%+68.14%+42.32% 35TCr
+2.38%+4.27%+33.81%+57.95% 29TCr
+2.26%+3.47%+5.21%+28.92% 26TCr
+1.97%+5.11%+57.74%+76.14% 24TCr
+4.03%+7.84%+40.49%+116.14% 20TCr
Average +2.83%+1.39%+44.64%+81.55% 44.86TCr
Weighted average by Cap. +3.91%+1.50%+49.58%+95.97%

Financials

2026 *2027 *
Net sales 1.43TCr 43Cr 38Cr 35Cr 32Cr 59Cr 4.05TCr 60Cr 419.07Cr 167.19Cr 2.12TCr 159.53Cr 156.13Cr 6.71TCr 1.55TCr 46Cr 41Cr 38Cr 34Cr 64Cr 4.38TCr 65Cr 453.25Cr 180.82Cr 2.29TCr 172.54Cr 168.87Cr 7.26TCr
Net income 224.3Cr 6.65Cr 5.96Cr 5.5Cr 4.98Cr 9.3Cr 633.6Cr 9.45Cr 66Cr 26Cr 331.59Cr 25Cr 24Cr 1.05TCr 248.59Cr 7.37Cr 6.6Cr 6.09Cr 5.51Cr 10Cr 702.21Cr 10Cr 73Cr 29Cr 367.5Cr 28Cr 27Cr 1.16TCr
Net Debt -461.67Cr -14Cr -12Cr -11Cr -10Cr -19Cr -1.3TCr -19Cr -135.01Cr -54Cr -682.51Cr -51Cr -50Cr -2.16TCr -471.98Cr -14Cr -13Cr -12Cr -10Cr -20Cr -1.33TCr -20Cr -138.02Cr -55Cr -697.74Cr -53Cr -51Cr -2.21TCr
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
29/26/29 THB 32.75 -3.68% 23,71,500
28/26/28 THB 34.00 0.00% 9,34,500
27/26/27 THB 34.00 -0.73% 20,93,700
26/26/26 THB 34.25 -0.72% 18,47,000
22/26/22 THB 34.50 +2.99% 7,10,200
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
32.75THB
Average target price
42.71THB
Spread / Average Target
+30.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Mega Lifesciences